Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines

Circulation

Volumn 96, Issue 8, 1997, Pages 2667-2674

  Van Belle, Eric ^a   Rivard, Alain ^c   Chen, Donghui ^c   Silver, Marcy ^c   Bunting, Stuart ^b   Ferrara, Napoleon ^b   Symes, James F ^c   Bauters, Christophe ^a   Isner, Jeffrey M ^c,d  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b GENENTECH INC   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Atherosclerosis; Growth factors; Hypercholesterolemia

Indexed keywords

CYTOKINE; RECOMBINANT VASCULOTROPIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; COLLATERAL CIRCULATION; CONTROLLED STUDY; DOSE RESPONSE; GASTROCNEMIUS MUSCLE; HINDLIMB; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LIMB ISCHEMIA; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0030853575     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.8.2667     Document Type: Article

References (33)

1. D'Amore PA, Thompson RW. Mechanisms of angiogenesis. Annu Rev Physiol. 1987;49:453-464.
2. Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992;267:10931-10934.
3. Isner JM, Walsh K, Symes JF, Piezcek A, Takeshita S, Lowry J, Rosenfield K, Weir L, Brogi E, Jurayj D. Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease. Circulation. 1995;91:2687-2692.
4. White FC, Carroll SM, Magnet A, Bloor CM. Coronary collateral development in swine after coronary artery occlusion. Circ Res. 1992;71:1490-1500.
5. Sellke FW, Quillen JE, Brooks LA, Harrison DG. Endothelial modulation of the coronary vasculature in vessels perfused via mature collaterals. Circulation. 1990;81:1938-1947.
6. Unger EF, Sheffield CD, Epstein SE. Heparin promotes the formation of extracardiac to coronary anastomoses in a canine model. Am J Physiol. 1991;260:H1625-H1634.
7. Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM. Physiologic assessment of angiogenesis induced by vascular endothelial growth factor in a rabbit ischemic hindlimb model. Am J Physiol. 1994;36:H1263-H1271.
8. Watanabe Y. Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit). Atherosclerosis. 1980;36:261-268.
9. Tanzawa K, Shimada Y, Kuroda M, Tsujita Y, Arai M, Watanabe H. WHHL-rabbit: a low density lipoprotein receptor-deficient animal model of familial hypercholesterolemia. FEBS Lett. 1980; 118:81-84.
10. Kolodgie FD, Virmani R, Rice HE, Mergner WJ. Vascular reactivity during the progression of atherosclerotic plaque: a study in Watanabe heritable hyperlipidemic rabbits. Circ Res. 1990;66: 1112-1126.
11. Atkinson JB, Swift LL, Virmani R. Animal model of human disease: Watanabe heritable hyperlipidemic rabbit: familial hypercholesterolemia. Am J Pathol. 1992;140:749-753.
12. Tagawa H, Tomoike H, Nakamura M. Putative mechanisms of the impairment of endothelium-dependent relaxation of the aorta with atheromatous plaques in heritable hyperlipidemic rabbits. Circ Res. 1991;68:330-337.
13. Buja LM, Kita T, Goldstein JL, Watanabe Y, Brown MS. Cellular pathology of progressive atherosclerosis in the WHHL rabbit: an animal model of familial hypercholesterolemia. Arteriosclerosis. 1983;3:87-101.
14. Walter DH, Hink U, Asahara T, Van Belle E, Horowitz J, Tsurumi Y, Vandlen R, Heinsohn H, Keyt B, Ferrara N, Symes JF, Isner JM. The in vivo bioactivity of vascular endothelial growth factor/ vascular permeability factor is independent of N-linked glycosylation. Lab Invest. 1996;74:546-556.
15. Horowitz J, Hariawala M, Sheriff DD, Keyt B, Symes JF. In vivo administration of vascular endothelial growth factor is associated with EDRF-dependent systemic hypotension in porcine and rabbit animal models. Circulation. 1995;92:I-630-I-631. Abstract.
16. Doucette JW, Corl PD, Payne HM, Flynn AE, Goto M, Nassi M, Segal J. Validation of a Doppler wire for intravascular measurements of coronary artery flow velocity. Circulation. 1992;85: 1899-1911.
17. Kowallik P, Schulz R, Guth BD, Schade A, Paffhausen W, Gross R, Heusch G. Measurement of regional myocardial blood flow with multiple colored microspheres. Circulation. 1991;83:974-982.
18. Ziada AM, Hudlicka O, Tyler KR, Wright AJ. The effect of long-term vasodilation on capillary growth and performance in rabbit heart and skeletal muscle. Cardiovasc Res. 1984;18:724-732.
19. Isayama K, Pitts LH, Nishimura MC. Evaluation of 2,3,5-triphenyltetrazolium chloride staining to delineate rat brain infarcts. Stroke. 1991;22:1394-1398.
20. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF, Isner JM. Therapeutic angiogenesis: a single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model. J Clin Invest. 1994;93:662-670.
21. Haulers C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM. Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. Circulation. 1995;91:2802-2809.
22. Asahara T, Haulers C, Pastore CJ, Kearney M, Rossow S, Bunting S, Ferrara N, Symes JF, Isner JM. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimai hyperplasia in balloon-injured rat carotid artery. Circulation. 1995;91:2793-2801.
23. 165 gene transfer. Circulation. 1996;94:3291-3302.
24. Chen CH, Nguyen HH, Weilbaecher D, Luo S, Gotto AM Jr, Henry PD. Basic fibroblast growth factor reverses atherosclerotic impairment of human coronary angiogenesis-like response in vitro. Atherosclerosis. 1995;116:261-268.
25. Risau W. Differentiation of endothelium. FASEB J. 1995;9:926-933.
26. Takeshita S, Rossow ST, Kearney M, Zheng LP, Bauters C, Bunting S, Ferrara N, Symes JF, Isner JM. Time course of increased cellular proliferation in collateral arteries following administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency. Am J Pathol. 1995;147: 1649-1660.
27. Murugesan G, Fox PL. Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein. J Clin Invest. 1996;97:2736-2744.
28. Namiki A, Brogi E, Kearney M, Wu T, Couffinhal T, Varticovski L, Isner JM. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem. 1995;270:31189-31195.
29. Brogi E, Schatteman G, Wu T, Kim EA, Varticovski L, Keyt B, Isner JM. Hypoxia-induced paracrine regulation of VEGF receptor expression. J Clin Invest. 1996;97:469-476.
30. Bossaller C, Habib BG, Yamamoto H, Williams C, Wells S, Henry PD. Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5′-monophasphate formation in atherosclerotic human coronary artery and rabbit aorta. J Clin Invest 1987;79: 170-174.
31. Kugiyama K, Kerns S, Morisset JD, Roberts R, Henry PD. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature Med. 1990;344:160-162.
32. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86:353-364.
33. Meurice T, Bauters C, Auffray J-L, Vallet B, Hamon M, Valero F, Van Belle E, Lablanche J-M, Bertrand ME. Basic fibroblast growth factor restores endothelium-dependent responses after balloon injury of rabbit arteries. Circulation. 1996;93:18-22.